CG Oncology (CGON) Payables (2023 - 2025)
Historic Payables for CG Oncology (CGON) over the last 3 years, with Q3 2025 value amounting to $9.2 million.
- CG Oncology's Payables fell 1885.43% to $9.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.2 million, marking a year-over-year decrease of 1885.43%. This contributed to the annual value of $6.5 million for FY2024, which is 10101.79% up from last year.
- CG Oncology's Payables amounted to $9.2 million in Q3 2025, which was down 1885.43% from $7.1 million recorded in Q2 2025.
- In the past 5 years, CG Oncology's Payables ranged from a high of $11.3 million in Q3 2024 and a low of $3.2 million during Q4 2023
- In the last 3 years, CG Oncology's Payables had a median value of $6.9 million in 2024 and averaged $7.0 million.
- In the last 5 years, CG Oncology's Payables surged by 10101.79% in 2024 and then crashed by 1885.43% in 2025.
- Over the past 3 years, CG Oncology's Payables (Quarter) stood at $3.2 million in 2023, then skyrocketed by 101.02% to $6.5 million in 2024, then surged by 41.06% to $9.2 million in 2025.
- Its Payables was $9.2 million in Q3 2025, compared to $7.1 million in Q2 2025 and $6.7 million in Q1 2025.